«At the same time, as the human ZNF217 is associated with poor
survival in a variety of cancers, understanding how this protein operates in physiological conditions may help to predict cancer risk, achieve earlier diagnosis and provide novel therapeutic approaches.»
We have also participated
in events with a
variety of organizations such as SC's CancerCon and the OMG Stupid
Cancer Summit, the Young
Survival Coalition, and the Oncofertility Consortium and Gilda's Club.